News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
804,504 Results
Type
Article (73542)
Company Profile (697)
Press Release (730265)
Section
Business (226182)
Career Advice (3706)
Deals (39125)
Drug Delivery (122)
Drug Development (88792)
Employer Resources (194)
FDA (17709)
Job Trends (17035)
News (385495)
Policy (38535)
Tag
Academia (2974)
Alliances (55634)
Alzheimer's disease (1393)
Approvals (17638)
Artificial intelligence (190)
Bankruptcy (393)
Best Places to Work (12590)
Biotechnology (477)
Breast cancer (214)
Cancer (1600)
Cardiovascular disease (138)
Career advice (3152)
Cell therapy (346)
Clinical research (70763)
Collaboration (602)
Compensation (313)
COVID-19 (2820)
C-suite (142)
Data (1500)
Diabetes (206)
Diagnostics (6731)
Earnings (91660)
Employer resources (167)
Events (126392)
Executive appointments (486)
FDA (18504)
Funding (533)
Gene therapy (244)
GLP-1 (739)
Government (5009)
Healthcare (20780)
Infectious disease (2925)
Inflammatory bowel disease (127)
Interviews (723)
IPO (17577)
Job creations (4932)
Job search strategy (2584)
Layoffs (501)
Legal (9831)
Lung cancer (241)
Manufacturing (243)
Medical device (14460)
Medtech (14465)
Mergers & acquisitions (21769)
Metabolic disorders (568)
Neuroscience (1787)
NextGen: Class of 2025 (7624)
Non-profit (5071)
Northern California (1901)
Obesity (324)
Opinion (252)
Patents (140)
People (63043)
Pharmaceutical (142)
Phase I (21848)
Phase II (30872)
Phase III (23287)
Pipeline (627)
Postmarket research (3237)
Preclinical (9593)
Radiopharmaceuticals (260)
Rare diseases (313)
Real estate (7096)
Regulatory (25394)
Research institute (2644)
Resumes & cover letters (580)
Southern California (1647)
Startups (4175)
United States (17591)
Vaccines (677)
Weight loss (251)
Date
Today (107)
Last 7 days (940)
Last 30 days (2288)
Last 365 days (37641)
2025 (1465)
2024 (37939)
2023 (42568)
2022 (53926)
2021 (58722)
2020 (57667)
2019 (51305)
2018 (39084)
2017 (36787)
2016 (37677)
2015 (43661)
2014 (38256)
2013 (34183)
2012 (36133)
2011 (36208)
2010 (35535)
Location
Africa (1180)
Arizona (213)
Asia (48005)
Australia (8240)
California (4416)
Canada (1558)
China (371)
Colorado (201)
Connecticut (222)
Europe (108195)
Florida (606)
Georgia (152)
Illinois (479)
Indiana (258)
Maryland (734)
Massachusetts (3521)
Michigan (202)
Minnesota (338)
New Jersey (1236)
New York (1232)
North Carolina (917)
Northern California (1901)
Ohio (161)
Pennsylvania (1016)
South America (1557)
Southern California (1647)
Texas (642)
Utah (126)
Washington State (464)
804,504 Results for "orient europharma co ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
OncoVent, a Subsidiary of Hepalink, Enters into a License and Distribution Agreement with Orient EuroPharma for the Immunotherapeutic Candidate Oregovomab
OncoVent Co., Ltd., a majority-controlled subsidiary of Shenzhen Hepalink Pharmaceutical Group Co., Ltd., yesterday entered into a license agreement with Orient EuroPharma Co., Ltd..
March 28, 2023
·
5 min read
Press Releases
Meiji Seika Pharma: Announcement of the Establishment of Local Subsidiary “Taiwan Meiji Pharma Co., Ltd.” in Taiwan
December 25, 2024
·
1 min read
Press Releases
Park Ha Biological Technology Co., Ltd. Announces Closing of $4.8 Million Initial Public Offering
December 31, 2024
·
4 min read
Press Releases
Park Ha Biological Technology Co., Ltd. Announces Pricing of $4.8 Million Initial Public Offering
December 26, 2024
·
4 min read
Meihua International Medical Technologies Co., Ltd. Announces Share Repurchase Program of Up to $3 million
Meihua International Medical Technologies Co., Ltd., a reputable manufacturer and provider of Class I, II and III disposable medical devices with operating subsidiaries in China, announced that its board of directors has approved and authorized a share repurchase program of up to $3 million of the Company’s outstanding ordinary shares.
July 1, 2024
·
5 min read
Drug Development
Rege Nephro CO., Ltd. Announces Patient Enrollment for Phase II Clinical Trial of Tamibarotene for ADPKD
Rege Nephro CO., Ltd. (https://www.regenephro.co.jp/en) has announced that patient enrollment began in April for the second stage of its Phase II clinical trial of tamibarotene as a developmental product for the treatment of autosomal dominant polycystic kidney disease (ADPKD) under the code RN-014.
May 28, 2024
·
2 min read
Press Releases
Newron and EA Pharma (A Subsidiary of Eisai Co., Ltd.) Announce License Agreement for Evenamide in Japan and Other Asian Territories
December 13, 2024
·
11 min read
Press Releases
Inari Medical Announces Reimbursement Approval for ClotTriever® Thrombectomy System in Japan and New Distribution Partnership with Medikit Co., Ltd.
December 3, 2024
·
4 min read
Press Releases
Lakeside Holding Enters Medical Logistics Sector with Acquisition of Hupan Pharmaceutical (Hubei) Co., Ltd.
November 11, 2024
·
4 min read
BioMidwest
AriBio Co., Ltd. Announces Strategic Collaboration with Kentucky Clinical Trial Laboratory (KCTL) to Expand Alzheimer’s Disease Testing
AriBio Co., Ltd. announces the expansion of testing for Alzheimer’s disease by entering into a strategic collaboration with Kentucky Clinical Trial Laboratory for the testing of cerebral spinal fluid to accurately and efficiently aid in the diagnosis of Alzheimer’s disease using the Lumipulse® system from FujireBio.
June 21, 2024
·
3 min read
1 of 80,451
Next
